NCT01780740View on ClinicalTrials.gov

Statin Therapy In Atrial Refractoriness and Reperfusion Injury

PHASE4CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

August 31, 2014

Study Completion Date

August 31, 2014

Conditions
Disorder; Heart, Functional, Postoperative, Cardiac SurgeryCardiac Insufficiency Following Cardiac SurgeryAtrial FibrillationIschaemia-reperfusion Injury
Interventions
DRUG

Atorvastatin

Atorvastatin (80 mg od) started not earlier than 6 days before surgery and continued until the 5th post-operative day included;

DRUG

Placebo

Placebo started not earlier than 6 days before surgery and continued until the 5th post-operative day included;

Trial Locations (1)

OX3 9DU

Oxford University Hospitals NHS trust, Oxford

All Listed Sponsors
lead

University of Oxford

OTHER

NCT01780740 - Statin Therapy In Atrial Refractoriness and Reperfusion Injury | Biotech Hunter | Biotech Hunter